CHERYL ELDRIDGE: Open Payments
NPI 1235620071 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 30 payments from 11 companies in 2025. Trend: 2023 $624 · 2024 $361 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $261 |
| Axsome Therapeutics, Inc. | 4 | $73 |
| Lilly USA, LLC | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Verona Pharma, Inc. | 2 | $28 |
| Novo Nordisk Inc | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: VRAYLAR, Auvelity, JARDIANCE, GVOKE HYPOPEN, CAPLYTA, XIFAXAN, INSPIRE, Ohtuvayre.
Industry payments across GA — which companies pay providers there.
